Novel antineoplastic compound medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGYIN TIANJIANG PHARMA
- Publication Date
- 2007-09-26
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
1. Technical field
[0001] The invention relates to a composition comprising ginseng or its extract, Ophiopogon japonicus or its extract, Schisandra chinensis or its extract, and at least one antitumor drug composition, its preparation method and application, and belongs to the field of medical technology . 2. Background technology
[0002] Cancer is a kind of disease that seriously threatens human life and health. According to statistics, about 1 million cancer patients are newly discovered in my country every year, while the world kills about 6 million people every year, and puts 10 million people on the verge of death. With the deteriorating environment of human beings, the occurrence of cancer The rate is increasing year by year. The World Health Organization predicts that cancer will become the "first killer" of human beings in the 21st century. At present, the treatment of cancer in modern medicine is mainly surgical treatment combined with radiotherapy and chemothera...